The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study

Plaß D, Mangen MJJ, Pinheiro JP, Gilsdorf A, Krause G, Gibbons CL, van Lier A, Krämer A, McDonald SA, Brooke RJ, Kramarz P, et al. (2014)
Epidemiology & Infection 142(10): 2024-2035.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Plaß, DietrichUniBi; Mangen, M.J.J.; Pinheiro, Joao PauloUniBi; Gilsdorf, A.; Krause, G.; Gibbons, C.L.; van Lier, A.; Krämer, AlexanderUniBi ; McDonald, S.A.; Brooke, R.J.; Kramarz, P.; Cassini, A.
Alle
Abstract / Bemerkung
Setting priorities in the field of infectious diseases requires evidence-based and robust baseline estimates of disease burden. Therefore, the European Centre for Disease Prevention and Control initiated the Burden of Communicable Diseases in Europe (BCoDE) project. The project uses an incidence- and pathogen-based approach to measure the impact of both acute illness and sequelae of infectious diseases expressed in disability-adjusted life years (DALYs). This study presents first estimates of disease burden for four pathogens in Germany. The number of reported incident cases adjusted for underestimation served as model input. For the study period 2005–2007, the average disease burden was estimated at 33 116 DALYs/year for influenza virus, 19 115 DALYs/year for Salmonella spp., 8708 DALYs/year for hepatitis B virus and 740 DALYs/year for measles virus. This methodology highlights the importance of sequelae, particularly for hepatitis B and salmonellosis, because if omitted, the burden would have been underestimated by 98% and 56%, respectively.
Erscheinungsjahr
2014
Zeitschriftentitel
Epidemiology & Infection
Band
142
Ausgabe
10
Seite(n)
2024-2035
ISSN
0950-2688
Page URI
https://pub.uni-bielefeld.de/record/2675243

Zitieren

Plaß D, Mangen MJJ, Pinheiro JP, et al. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study. Epidemiology & Infection. 2014;142(10):2024-2035.
Plaß, D., Mangen, M. J. J., Pinheiro, J. P., Gilsdorf, A., Krause, G., Gibbons, C. L., van Lier, A., et al. (2014). The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study. Epidemiology & Infection, 142(10), 2024-2035. doi:10.1071/S0950268813003312
Plaß, Dietrich, Mangen, M.J.J., Pinheiro, Joao Paulo, Gilsdorf, A., Krause, G., Gibbons, C.L., van Lier, A., et al. 2014. “The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study”. Epidemiology & Infection 142 (10): 2024-2035.
Plaß, D., Mangen, M. J. J., Pinheiro, J. P., Gilsdorf, A., Krause, G., Gibbons, C. L., van Lier, A., Krämer, A., McDonald, S. A., Brooke, R. J., et al. (2014). The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study. Epidemiology & Infection 142, 2024-2035.
Plaß, D., et al., 2014. The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study. Epidemiology & Infection, 142(10), p 2024-2035.
D. Plaß, et al., “The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study”, Epidemiology & Infection, vol. 142, 2014, pp. 2024-2035.
Plaß, D., Mangen, M.J.J., Pinheiro, J.P., Gilsdorf, A., Krause, G., Gibbons, C.L., van Lier, A., Krämer, A., McDonald, S.A., Brooke, R.J., Kramarz, P., Cassini, A., Kretzschmar, M.E.E.: The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study. Epidemiology & Infection. 142, 2024-2035 (2014).
Plaß, Dietrich, Mangen, M.J.J., Pinheiro, Joao Paulo, Gilsdorf, A., Krause, G., Gibbons, C.L., van Lier, A., Krämer, Alexander, McDonald, S.A., Brooke, R.J., Kramarz, P., Cassini, A., and Kretzschmar, M.E.E. “The disease burden of hepatitis B, influenza, measles and salmonellosis in Germany: first results of the Burden of Communicable Diseases in Europe Study”. Epidemiology & Infection 142.10 (2014): 2024-2035.

10 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

The disease burden associated with Campylobacter spp. in Germany, 2014.
Lackner J, Weiss M, Müller-Graf C, Greiner M., PLoS One 14(5), 2019
PMID: 31091282
Optimizing the impact of low-efficacy influenza vaccines.
Sah P, Medlock J, Fitzpatrick MC, Singer BH, Galvani AP., Proc Natl Acad Sci U S A 115(20), 2018
PMID: 29712866
A Software Tool for Estimation of Burden of Infectious Diseases in Europe Using Incidence-Based Disability Adjusted Life Years.
Colzani E, Cassini A, Lewandowski D, Mangen MJ, Plass D, McDonald SA, van Lier A, Haagsma JA, Maringhini G, Pini A, Kramarz P, Kretzschmar ME., PLoS One 12(1), 2017
PMID: 28107447
Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020.
Maertens de Noordhout C, Devleesschauwer B, Haagsma JA, Havelaar AH, Bertrand S, Vandenberg O, Quoilin S, Brandt PT, Speybroeck N., Euro Surveill 22(38), 2017
PMID: 28935025
Burden and spectrum of infectious disease in Germany 2009-2014: a multicentre study from Berlin's Municipal Hospitals.
Katchanov J, Wöstmann K, Tominski D, Jefferys L, Liedtke A, Schneider A, Slevogt H, Arastéh K, Stocker H., Infection 44(2), 2016
PMID: 26311655
Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.
van Lier A, McDonald SA, Bouwknegt M, EPI group, Kretzschmar ME, Havelaar AH, Mangen MJ, Wallinga J, de Melker HE., PLoS One 11(4), 2016
PMID: 27097024
Underreporting of hepatitis A in non-endemic countries: a systematic review and meta-analysis.
Savage RD, Rosella LC, Brown KA, Khan K, Crowcroft NS., BMC Infect Dis 16(), 2016
PMID: 27297559
Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium.
Gerlier L, Lamotte M, Dos Santos Mendes S, Damm O, Schwehm M, Eichner M., Paediatr Drugs 18(4), 2016
PMID: 27272706
Epidemiology and economic burden of measles, mumps, pertussis, and varicella in Germany: a systematic review.
Damm O, Witte J, Wetzka S, Prosser C, Braun S, Welte R, Greiner W., Int J Public Health 61(7), 2016
PMID: 27488917
The impact of individual-level heterogeneity on estimated infectious disease burden: a simulation study.
McDonald SA, Devleesschauwer B, Wallinga J., Popul Health Metr 14(), 2016
PMID: 27931225

25 References

Daten bereitgestellt von Europe PubMed Central.

Community incidence of pathogen-specific gastroenteritis: reconstructing the surveillance pyramid for seven pathogens in seven European Union member states.
Haagsma JA, Geenen PL, Ethelberg S, Fetsch A, Hansdotter F, Jansen A, Korsgaard H, O'Brien SJ, Scavia G, Spitznagel H, Stefanoff P, Tam CC, Havelaar AH; Med-Vet-Net Working Group, Adak G, Andersson Y, Ivarsson S, Kasbohrer A, Maciag A, Molbak K, Stark K, Sundstrom K, Thebault A, Wahlstrom H, van der Zanden B, Zielinski A., Epidemiol. Infect. 141(8), 2012
PMID: 23013659
Estimating the true incidence of campylobacteriosis and salmonellosis in the European Union, 2009.
Havelaar AH, Ivarsson S, Lofdahl M, Nauta MJ., Epidemiol. Infect. 141(2), 2012
PMID: 22717051

AUTHOR UNKNOWN, Eurosurveillance 12(), 2007
Health burden in the Netherlands due to infection with thermophilic Campylobacter spp.
Havelaar AH, de Wit MA, van Koningsveld R, van Kempen E., Epidemiol. Infect. 125(3), 2000
PMID: 11218201

AUTHOR UNKNOWN, International Journal of Cancer 118(), 2006
New methodology for estimating the burden of infectious diseases in Europe.
Kretzschmar M, Mangen MJ, Pinheiro P, Jahn B, Fevre EM, Longhi S, Lai T, Havelaar AH, Stein C, Cassini A, Kramarz P; BCoDE consortium, Havelaar A, Kretzschmar M, van Lier A, McDonald S, Brooke J, Haagsma J, Mangen MJ, de Wit A, Kramer A, Pinheiro P, Plass D, Fevre E, Gibbons C, Franco E, Longhi S, Ricciardi W, de Waure C, Jahn B, Muhlberger N, Siebert U, Lai T, Matsi A, Ruutel K, Cassini A, Colzani E, Kramarz P, Achterberg P, Amato A, Coutinho R, Nanda A, Salminen M, Vos T., PLoS Med. 9(4), 2012
PMID: 22529750
Applying DALYs to the burden of infectious diseases.
Zou S., Bull. World Health Organ. 79(3), 2001
PMID: 11285678
The association between Helicobacter pylori infection and early gastric cancer: a meta-analysis.
Wang C, Yuan Y, Hunt RH., Am. J. Gastroenterol. 102(8), 2007
PMID: 17521398
Epidemiologic classification of human papillomavirus types associated with cervical cancer.
Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ; International Agency for Research on Cancer Multicenter Cervical Cancer Study Group., N. Engl. J. Med. 348(6), 2003
PMID: 12571259
Priority setting: what constitutes success? A conceptual framework for successful priority setting.
Sibbald SL, Singer PA, Upshur R, Martin DK., BMC Health Serv Res 9(), 2009
PMID: 19265518
Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011.
Balabanova Y, Gilsdorf A, Buda S, Burger R, Eckmanns T, Gartner B, Gross U, Haas W, Hamouda O, Hubner J, Janisch T, Kist M, Kramer MH, Ledig T, Mielke M, Pulz M, Stark K, Suttorp N, Ulbrich U, Wichmann O, Krause G., PLoS ONE 6(10), 2011
PMID: 21991334
Setting priorities in clinical and health services research: properties of an adapted and updated method.
Berra S, Sanchez E, Pons JM, Tebe C, Alonso J, Aymerich M., Int J Technol Assess Health Care 26(2), 2010
PMID: 20392327
Evaluating priority setting success in healthcare: a pilot study.
Sibbald SL, Gibson JL, Singer PA, Upshur R, Martin DK., BMC Health Serv Res 10(), 2010
PMID: 20482843

AUTHOR UNKNOWN, Health Research Policy and Systems 8(), 2010

AUTHOR UNKNOWN, European Journal of Public Health 21(), 2011
The global burden of measles in the year 2000--a model that uses country-specific indicators.
Stein CE, Birmingham M, Kurian M, Duclos P, Strebel P., J. Infect. Dis. 187 Suppl 1(), 2003
PMID: 12721886
Large measles outbreak at a German public school, 2006.
Wichmann O, Hellenbrand W, Sagebiel D, Santibanez S, Ahlemeyer G, Vogt G, Siedler A, van Treeck U., Pediatr. Infect. Dis. J. 26(9), 2007
PMID: 17721371
Long time trends in influenza-like illness and associated determinants in The Netherlands.
Dijkstra F, Donker GA, Wilbrink B, Van Gageldonk-Lafeber AB, Van Der Sande MA., Epidemiol. Infect. 137(4), 2008
PMID: 18789176
Control of hepatitis B in the United Kingdom.
Ramsay M, Gay N, Balogun K, Collins M., Vaccine 16 Suppl(), 1998
PMID: 9915036
The effect of underreporting on the apparent incidence and epidemiology of acute viral hepatitis.
Alter MJ, Mares A, Hadler SC, Maynard JE., Am. J. Epidemiol. 125(1), 1987
PMID: 3098091
The burden of disease and injury in the United States 1996.
Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M, Bulzacchelli MT, Ebrahim S, Ezzati M, Salomon JA, Kreiser JG, Hogan M, Murray CJ., Popul Health Metr 4(), 2006
PMID: 17049081
Internal construct validity of the Shirom-Melamed Burnout Questionnaire (SMBQ).
Lundgren-Nilsson A, Jonsdottir IH, Pallant J, Ahlborg G Jr., BMC Public Health 12(), 2012
PMID: 22214479
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 24480146
PubMed | Europe PMC

Suchen in

Google Scholar